These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12396967)

  • 1. Pathways to primary neurodegenerative disease.
    Hardy J
    Neurologia; 2002 Oct; 17(8):399-401. PubMed ID: 12396967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M; Wolozin B
    Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
    [No Abstract]   [Full Text] [Related]  

  • 3. Interface between tauopathies and synucleinopathies: a tale of two proteins.
    Galpern WR; Lang AE
    Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of aggregates and protein inclusions by staining of tissues.
    Galvin JE
    Methods Mol Biol; 2003; 232():149-64. PubMed ID: 12840547
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenic effects of alpha-synuclein aggregation.
    Lundvig D; Lindersson E; Jensen PH
    Brain Res Mol Brain Res; 2005 Mar; 134(1):3-17. PubMed ID: 15790525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.
    Verbeek MM; De Jong D; Kremer HP
    Ann Clin Biochem; 2003 Jan; 40(Pt 1):25-40. PubMed ID: 12542908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegenerative disease: a different view of diagnosis.
    Hardy J; Gwinn-Hardy K
    Mol Med Today; 1999 Dec; 5(12):514-7. PubMed ID: 10562716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.
    Forman MS; Trojanowski JQ; Lee VM
    Nat Med; 2004 Oct; 10(10):1055-63. PubMed ID: 15459709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein and transgenic mouse models.
    Fernagut PO; Chesselet MF
    Neurobiol Dis; 2004 Nov; 17(2):123-30. PubMed ID: 15474350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
    Armstrong RA; Lantos PL; Cairns NJ
    Neuropathology; 2008 Aug; 28(4):351-65. PubMed ID: 18433435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
    Lees AJ
    Mov Disord; 2003 Sep; 18 Suppl 6():S28-33. PubMed ID: 14502653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatamopathological spectrum of tauopathies.
    Revesz T; Holton JL
    Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein aggregation and its relation to neurodegenerative diseases.
    Papapetropoulos S; Mash DC
    Ann Neurol; 2005 Apr; 57(4):605; author reply 605-6. PubMed ID: 15786478
    [No Abstract]   [Full Text] [Related]  

  • 18. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.
    Schraen-Maschke S; Dhaenens CM; Delacourte A; Sablonnière B
    Neurobiol Dis; 2004 Apr; 15(3):449-60. PubMed ID: 15056452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A; Lippa CF; Lee VM; Trojanowski JQ
    Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a molecular neuropsychiatry of neurodegenerative diseases.
    Cummings JL
    Ann Neurol; 2003 Aug; 54(2):147-54. PubMed ID: 12891666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.